The neonatal variant of Bartter syndrome and deafness: Preservation of renal function

Pediatrics

Volumn 112, Issue 3 I, 2003, Pages 628-633

  Shalev, Hanna ^a   Ohali, Melly ^b   Kachko, Leonid ^a   Landau, Daniel ^a  

^a BEN GURION UNIVERSITY OF THE NEGEV   (Israel)

^b BEN GURION UNIVERSITY OF THE NEGEV   (Israel)

Author keywords

Bartter's disease; Glomerular filtration rate; Hearing loss; Interstitial; Nephritis; Sensorineural

Indexed keywords

ARTICLE; BARTTER SYNDROME; CELL PROLIFERATION; CHILD; CLINICAL ARTICLE; CREATININE CLEARANCE; FEMALE; GLOMERULUS FILTRATION RATE; HEARING IMPAIRMENT; HUMAN; HYPERALDOSTERONISM; HYPERCALCIURIA; HYPOKALEMIA; INFANT; KIDNEY BIOPSY; KIDNEY FUNCTION; MALE; MESANGIUM CELL; MULTIGENE FAMILY; PERCEPTION DEAFNESS; PRIORITY JOURNAL;

ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ARABS; CHROMOSOMES, HUMAN, PAIR 1; DIETARY SUPPLEMENTS; FEMALE; FLUID THERAPY; FOUNDER EFFECT; HEARING LOSS, SENSORINEURAL; HUMANS; INAPPROPRIATE ADH SYNDROME; INDOMETHACIN; INFANT, NEWBORN; INFANT, PREMATURE; KIDNEY FAILURE, CHRONIC; MALE; POTASSIUM, DIETARY; RETROSPECTIVE STUDIES;

EID: 0042839701     PISSN: 00314005     EISSN: None     Source Type: Journal    
DOI: 10.1542/peds.112.3.628     Document Type: Article

References (22)

1. Sutton RA, Mavichak V, Halabe A, Wilkins GE. Bartter's syndrome: evidence suggesting a distal tubular defect in a hypocalciuric variant of the syndrome. Miner Electrolyte Metab. 1992;18:43-51
2. Köckerling A, Reinalter SC, Seyberth HW. Impaired response to furosemide in hyperprostaglandin E syndrome: evidence for a tubular defect in the loop of Henle. J Pediatr. 1996;129:519-528
3. Hunter M. Accessory to kidney disease. Nature. 2001;414:502-503
4. Landau D, Shalev H, Ohaly M, Carmi R. Infantile variant of Bartter syndrome and sensorineural deafness: a new autosomal recessive disorder. Am J Med Genet. 1995;59:454-458
5. - reabsorption and inner ear K+ secretion. Nature. 2001;414:558-561
6. Jeck N, Reinalter SC, Henne T, et al. Hypokalemic salt-losing tubulopathy with chronic renal failure and sensorineural deafness. Pediatrics. 2001;108(1). Available at: http://www.pediatrics.org/cgi/content/full/108/3/e5
7. Brennan TMH, Landau D, Shalev H, et al. Linkage of infantile Bartter syndrome with sensorineural deafness to chromosome 1p. Am J Hum Genet. 1998;62:355-361
8. Birkenhager R, Otto E, Schermann MJ, et al. Bartter syndrome with sensorineural deafness and kidney failure is caused by mutation of a new gene expressed in kidney and during inner ear development. Nature Genet. 2001;29:310-314
9. Konrad M, Leonhardt A, Hensen P, Seyberth HW, Kockerling A. Prenatal and postnatal management of hyperprostaglandin E syndrome after genetic diagnosis from amniocytes. Pediatrics. 1999;103:678-683
10. Schwartz GJ, Brion LP, Spitzer A. The use of plasma creatinine concentration for estimating glomerular filtration rate in infants, children, and adolescents. Pediatr Clin North Am. 1987;34:571-590
11. Makhoul IR, Sujov P, Smolkin T, Lusky A, Reichman B. Epidemiological, clinical and microbiological characteristics of late-onset sepsis among very low birth weight infants in Israel: a national survey. Pediatrics. 2002;109:34-39
12. Rudin A. Bartter's syndrome. A review of 28 patients followed for 10 years. Acta Med Scand. 1988;224:165-171
13. Sato K, Ogata M. A patient with chronic renal failure due to Bartter's syndrome. Nippon Jinzo Gakkai Shi. 1995;37:404-409
14. Reinalter SC, Grone HJ, Konrad M, Seyberth HW, Klaus G. Evaluation of long-term treatment with indomethacin in hereditary hypokalemic salt-losing tubulopathies. J Pediatr. 2001;139:398-406
15. Riemenschneider T, Bohle A. Morphologic aspects of low-potassium and low-sodium nephropathy. Clin Nephrol. 1983;19:271-279
16. Henrich WL, Agodoa LE, Barrett B, et al. Analgesics and the kidney: summary and recommendations to the Scientific Advisory Board of the National Kidney Foundation from an Ad Hoc Committee of the National Kidney Foundation. Am J Kidney Dis. 1996;27:162-165
17. Seidel C, Reinalter S, Seyberth HW, Scharer K. Pre-pubertal growth in the hyperprostaglandin E syndrome. Pediatr Nephrol. 1995;9:723-728
18. Seyberth HW, Rascher W, Schweer H, Kuhl PG, Mehls O, Scharer K. Congenital hypokalemia with hypercalciuria in preterm infants: a hyperprostaglandinuric tubular syndrome different from Bartter syndrome. J Pediatr. 1985;107:694-701
19. Pirson Y, van Ypersele de Strihou C. Renal side effects of nonsteroidal antiinflammatory drugs: clinical relevance. Am J Kidney Dis. 1986;8:338-344
20. Catterton Z, Sellers B, Gray B. Inulin clearance in the premature infant receiving indomethacin. J Pediatr. 1980;96:737-739
21. Finer G, Shalev H, Birk O, et al. Transient neonatal hyperkalemia in the antenatal (ROMK defective) Bartter syndrome. J Pediatr. 2003;142:318-323
22. Waldegger S, Jeck N, Barth P, et al. Barttin increases surface expression and changes current properties of CIC-K channels. Pflugers Arch. 2002;444:411-418